Welcome to our Press Room.
Your go-to source for the latest updates on our official communications.
Dr. Schär confirms the strength of its business model.
From the 2025 consolidation to a new growth cycle: €28 million in planned investments.
A Future Without Cages
Since 2016, Dr. Schär has pursued a rigorous process of supplier assessments and on-site audits to enhance quality and animal welfare standards throughout its entire supply chain. Today, the company has achieved a key milestone: all eggs used across its production sites worldwide now come exclusively from barn-raised hens. This result confirms Dr. Schär’s long-standing commitment to responsible sourcing, often anticipating local regulations and market trends.
International Coeliac Disease Awareness Day: Dr. Schär raises the bar for gluten-free quality.
On the occasion of International Coeliac Disease Awareness Day (16 May), Dr. Schär is renewing its commitment to increasingly balanced and sustainable gluten-free nutrition in line with the UN Sustainable Development Goals by continuing to optimise the nutritional content of Schär gluten-free products.
Dr. Schär closes 2024 above expectations
Dr. Schär, the leading Italian company for gluten-free and special nutrition, closed the 2024 financial year with a global turnover of GBP 524 million, up 11% on the previous year. Performance was positive in all regions, with around 70% of revenue generated by the foreign subsidiaries. Italy, Germany and the USA are the biggest markets. Key markets also include the United Kingdom, where Dr. Schär has a head office in Warrington and a gluten free bakery in Glasgow. The year-end results confirm the company’s financial strength and consolidate its leadership, also thanks to a significant investment of GBP 38 million in innovation and expansion. The double-digit growth is driven by the Schär brand and supported by a strategy focused on internationalisation and strengthening local production, key elements of a successful model.
Dr. Schär’s holistic approach for uncompromising quality.
“Quality comes first” sums up the approach to quality at Dr Schär, a world leader in gluten-free and special nutrition: a globally standardised process, localised in the 12 manufacturing plants, to maintain high quality, nutritional and safety standards in the finished products, which are available in more than 100 countries worldwide. A commitment in line with the company’s mission – to improve people’s lives –inside and outside the company.
Dr. Schär closes 2023 exceeding half a billion euros, global sales up 16%.
For Dr. Schär, global leader in gluten-free and special nutrition, performance was positive in all regions, with the United Kingdom remaining one of the top markets. The South Tyrolean company, led by Hannes Berger, consolidates its leadership and continues its growth strategy, aiming for global sales of €600 million by 2024.